Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-12,537
Closed -$592K 1571
2025
Q3
$592K Sell
12,537
-8,270
-40% -$399K 0.01% 605
2025
Q2
$1.01M Buy
+20,807
New +$1.06M 0.02% 611
2024
Q1
Sell
-11,668
Closed -$580K 2219
2023
Q4
$580K Buy
11,668
+6,099
+110% +$298K 0.01% 884
2023
Q3
$299K Sell
5,569
-4,439
-44% -$237K 0.01% 1183
2023
Q2
$539K Buy
+10,008
New +$538K 0.01% 797

Other funds holding SNY

Centiva Capital's SNY Position: Q4 2025 in Review

Centiva Capital sold out of Sanofi (SNY) in Q4 2025, closing a stake of 12,537 shares — an estimated $592K sold.

Centiva Capital first reported a position in SNY in Q2 2023 and held it in 5 quarters. The position peaked at $1.01M in Q2 2025. 757 funds tracked by Wall St. Rank hold SNY as of Q4 2025.

  • Centiva Capital reported no remaining Sanofi position as of Q4 2025 after selling out during the quarter.
  • Centiva Capital sold 12,537 Sanofi shares in Q4 2025, an estimated $592K.
  • Centiva Capital first reported a position in Sanofi in Q2 2023 and held it in 5 quarters.
  • Centiva Capital's Sanofi position peaked at $1.01M in Q2 2025.
  • 757 funds tracked by Wall St. Rank held Sanofi as of Q4 2025.

Based on Centiva Capital's 13F filing for Q4 2025, filed 13 Feb 2026.